Effects of sustained-release tulobuterol on asthma control and β-adrenoceptor function

Clinical and Experimental Pharmacology and Physiology

Volumn 29, Issue 12, 2002, Pages 1076-1083

  Kume, Hiroaki ^a,b   Kondo, Masashi ^a   Ito, Yasushi ^a   Suzuki, Ryujiro ^b   Yamaki, Kenichi ^a   Takagi, Kenzo ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

adrenoceptor; Airway smooth muscle; Desensitization; Patch formulation; Tolerance

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; METHACHOLINE; PROCATEROL; THEOPHYLLINE; TULOBUTEROL;

ADULT; ANIMAL TISSUE; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; GUINEA PIG; HUMAN; LUNG FUNCTION TEST; MALE; NONHUMAN; PEAK EXPIRATORY FLOW; PROTEIN FUNCTION; SMOOTH MUSCLE CONTRACTION; SUSTAINED RELEASE PREPARATION; SYMPTOM; TRACHEA MUSCLE; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; ADULT; ANALYSIS OF VARIANCE; ANIMALS; ASTHMA; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; RECEPTORS, ADRENERGIC, BETA; RESPIRATORY FUNCTION TESTS; TERBUTALINE; TRACHEA;

EID: 0036032972     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2002.03777.x     Document Type: Article

References (32)

1. Aveer BP, Jenne JW. Desensitization of isolated human bronchial smooth muscle to β-receptor agonists. J. Allergy Clin. Immunol. 1981; 68: 51-7.
2. Guillot C, Fornaris M, Badier M, Orehek J. Spontaneous and proved resistance to isoproterenol in isolated human bronchi. J. Allergy Clin. Immunol. 1984; 74: 713-18.
3. Willis-Karp M, Uchida Y, Lee Y, Jinot J, Hirata A, Hirata F. Organ culture with proinframmatory cytokines reproduces impairment of the β-adrenoceptor-mediated relaxation in tracheas of a guinea pig antigen model. Am. J. Respir. Cell Mol. Biol. 1993; 8: 153-9.
4. 2+ sensitization in tracheal smooth muscle. Am. J. Respir. Cell Mol. Biol. 2001; 25: 291-8.
5. Sears MR, Taylor DR, Print CG et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391-6.
6. Crockroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993; 342: 833-7.
7. Tan KS, Grove A, Mclean A, Gnosspelius Y, Hall IP, Lipworth BJ. Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am. J. Respir. Crit. Care Med. 1997; 156: 28-35.
8. Yates DH, Sussman HS, Shaw MJ, Barnes PJ, Chung KF. Regular formoterol treatment in mild asthma. Am. J. Respir. Crit. Care Med. 1995; 152: 1170-4.
9. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with asthma. N. Engl. J. Med. 1992; 327: 1198-203.
10. Pealman DS, Chervinsky P, LaForce C. A comparison of salmeterol with abuterol in the treatment of mild-to-moderate asthma. N. Engl. J. Med. 1992; 327: 1420-5.
11. Kesten S, Chapman KR, Broder I. A three-month comparison of twice daily inhaled formoterol versus four times daily albuterol in the management of stable asthma. Am. Rev. Respir. Dis. 1991; 144: 622-5.
12. Greening AP, Ind PW, Northield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219-24.
13. Woolcock A, Lundback B, Rindgal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am. J. Respir. Crit. Care Med. 1996; 153: 1481-8.
14. 2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation. Eur. J. Clin. Pharmacol. 1993; 44: 361-4.
15. Iikura Y, Uchiyama H, Akimoto K et al. Pharmacokinetics and pharmacodynamics of the tulobuterol patch, HN-078, in childhood asthma. Ann. Allergy Asthma Immunol. 1995; 74: 147-51.
16. s protein dysfunction in allergen-challenged human isolated passively sensitized bronchi. Am. J. Physiol. 2000; 279: L209-15.
17. s on desensitization of β-adrenergic receptors in tracheal smooth muscle. Am. J. Physiol. 1997; 273: L556-64.
18. Wada K, Minoguchi K, Kohno Y et al. Effects of a leukotriene receptor antagonists, pranlukast hydrate, on airway inflammation and airway hyperresponsiveness in patients with moderate to severe asthma. Allergol. Int. 2000; 49: 63-8.
19. Ca channels in the muscarinic and β-adrenergic regulation of airway smooth muscle. Am. J. Physiol. 1995; 268: L221-9.
20. Pauwels RA, Lofdahl C-G, Postma DS et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Eng. J. Med. 1997; 337: 1405-11.
21. Ca channels in human trachealis. Am. J. Respir. Crit. Care Med. 1999; 159: 452-60.
22. Mizutani H, Kume H, Ito Y, Takagi K, Yamaki K. Different effects of β-adrenoceptor desensitization on inhibitory actions in guinea-pig trachealis. Clin. Exp. Pharmacol. Physiol. 2002; 29: 646-54.
23. Miura M, Belvisi M, Stretton CD, Yacob MH, Barnes PJ. Role of potassium channels in bronchodilator response in human airways. Am. Rev. Respir. Dis. 1992; 146: 132-6.
24. Hiramatsu T, Kume H, Kotlikoff MI, Takagi K. Role of calcium-activated potassium channels in the relaxation of tracheal smooth muscles by forskolin. Clin. Exp. Pharmacol. Physiol. 1994; 21: 376-5.
25. +-channel activity in tracheal myocytes by phosphorylation. Nature 1989; 341: 152-4.
26. Nara M, Dhulipala PDK, Wang Y-X, Kotlikoff MI. Reconstruction of β-adrenergic modulation of large conductance, calcium-activated potassium (Maxi-K) channels in Xenopus oocytes. J. Biol. Chem. 1998; 273: 14 920-4.
27. Kume H, Graziano MP, Kotlikoff MI. Stimulatory and inhibitory regulation of calcium-activated potassium channels by guanine nucleotide-binding protein. Proc. Natl. Acad. Sci. USA 1992; 89: 11051-5.
28. Ca channels in airway smooth muscle by cAMP-dependent and -independent mechanisms. J. Clin. Invest. 1994; 93: 371-9.
29. Sudo Y, Kume H, Ito S, Ito Y, Yamaki K, Takagi K. Effects of direct and indirect activation of G protein of adenylyl cyclase on subsequent response to β-adrenergic receptor agonists in human trachealis. Arzneimittelforshung 2002 (in press).
30. Nelson HS, Berkowitz RB, Tinkelman DA, Emmett AH, Rickard KA, Yancey SW. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma. Am. J. Respir. Crit. Care Med. 1999; 159: 1556-61.
31. Anderson GP, Linden A, Rabe KF. Why are long-acting beta-adrenoceptor agonists long-acting? Eur. Respir. J. 1994; 7: 569-78.
32. Johnson M, Butchers PR, Coleman RA et al. The pharmacology of salmeterol. Life Sci. 1993; 52: 2131-43.